A Long-Term Extension Study to WA19926 (NCT01007435) of Tocilizumab in Participants With Early, Moderate to Severe Rheumatoid Arthritis

NCT01665430 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
38
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated by sponsor due to market authorization of tocilizumab for the study population.

Conditions

Interventions

Sponsor

Hoffmann-La Roche